Inventor · disambiguated record
Michael H. Reutershan
Also filed as: REUTERSHAN MICHAEL · REUTERSHAN MICHAEL H · REUTERSHAN MICHAEL HALE
20 granted patents·3 pending applications·85 citations·filing 2010–2025
91Inventor score
Files withMERCK SHARP & DOHME12MERCK SHARP & DOHME LLC4ALTMAN MICHAEL D3ALTMAN MICHAEL1FISCHER CHRISTIAN1
Top patents by PatentIndex Score
23 records- 0193US8735417B2Aminopyrimidines as Syk inhibitorsALTMAN MICHAEL D·Filed 2010·Granted May 27, 2014·35 cites·13 claims
- 0292US8551984B2Aminopyrimidines as SYK inhibitorsALTMAN MICHAEL D·Filed 2010·Granted Oct 8, 2013·25 cites·40 claims
- 0391US9242984B2Pyrazolyl derivatives as Syk inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Jan 26, 2016·12 cites·21 claims
- 0480US9376418B2Substituted pyridine spleen tyrosine kinase (SYK) inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Jun 28, 2016·5 cites·18 claims
- 0577US9682978B22,6,7 substituted purines as HDM2 inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Jun 20, 2017·2 cites·10 claims
- 0675US8962611B2Substituted imidazopyridines as HDM2 inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Feb 24, 2015·1 cites·20 claims
- 0775US8846657B2Substituted imidazopyridines as HDM2 inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Sep 30, 2014·1 cites·30 claims
- 0871US9487504B2Imidazolyl analogs as syk inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Nov 8, 2016·1 cites·7 claims
- 0970US9540377B22,6,7,8 substituted purines as HDM2 inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Jan 10, 2017·2 cites·15 claims
- 1065US10508108B2Tricyclic compounds as inhibitors of mutant IDH enzymesMERCK SHARP & DOHME·Filed 2015·Granted Dec 17, 2019·1 cites·20 claims
- 1156US2014243290A1Aminopyrimidines as SYK InhibitorsALTMAN MICHAEL D·Filed 2014·Application pending·0 cites
- 1254US11098059B2PRMT5 inhibitorsMERCK SHARP & DOHME·Filed 2018·Granted Aug 24, 2021·0 cites·3 claims
- 1352US9598405B2Thiazole-substituted aminopyridines as spleen tyrosine kinase inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Mar 21, 2017·0 cites·14 claims
- 1451US11993602B2PRMT5 inhibitorsMERCK SHARP & DOHME LLC·Filed 2019·Granted May 28, 2024·0 cites·17 claims
- 1550US11981701B2PRMT5 inhibitorsMERCK SHARP & DOHME LLC·Filed 2019·Granted May 14, 2024·0 cites·14 claims
- 1650US2023257371A1Cyclic cyanoenone derivatives as modulators of keap1ALTMAN MICHAEL·Filed 2021·Application pending·0 cites
- 1749US12441730B2PRMT5 inhibitorsMERCK SHARP & DOHME LLC·Filed 2020·Granted Oct 14, 2025·0 cites·14 claims
- 1846US12173026B2PRMT5 inhibitorsMERCK SHARP & DOHME LLC·Filed 2019·Granted Dec 24, 2024·0 cites·20 claims
- 1946US10947234B2PRMT5 inhibitorsMERCK SHARP & DOHME·Filed 2018·Granted Mar 16, 2021·0 cites·9 claims
- 2045US2025346600A1Tricyclic derivatives and related usesMOMA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2144US9637493B2Substituted pyrrolopyrimidines as HDM2 inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted May 2, 2017·0 cites·15 claims
- 2238US9586931B2Triazolyl derivatives as Syk inhibitorsMACHACEK MICHELLE R·Filed 2013·Granted Mar 7, 2017·0 cites·15 claims
- 2334US10442819B2Tricyclic compounds as inhibitors of mutant IDH enzymesFISCHER CHRISTIAN·Filed 2015·Granted Oct 15, 2019·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Michael H. Reutershan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →